Skip to main content

Entwicklung alternativer FCKW-freier Dosieraerosole - Perspektiven

  • Chapter
Pneumologische Umweltmedizin
  • 97 Accesses

Zusammenfassung

Weltweit gibt es etwa 60 Millionen Asthmakranke, davon leben allein in Deutschland etwa 3–4 Millionen, die auf eine Aerosoltherapie mit Medikamenten angewiesen sind. Nimmt man die chronisch obstruktive Bronchitis und das Lungenemphysem mit hinzu, so erhöht sich die Zahl dieser Kranken auf etwa 400 Millionen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Brain JD, Valberg PA (1979) Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 120:1325–1373

    PubMed  CAS  Google Scholar 

  2. June D (1995) Eine technisch neue Generation von Dosieraerosolen. Br J of Clin Pract, Suppl 79:S18–21

    Google Scholar 

  3. June DS, Ross D (1995) Improvement in dosing characteristics achieved with a new HFA salbutamol metered dose inhaler (MDI) as compared to a marketed CFC salbutamol MDI. European Respiratory Journal 8 (19): 1235

    Google Scholar 

  4. June DS, Ruble S, Ross R (1996) Reduced effect of temperature on drug delivery characteristics of CFC-free metered dose inhalers (MDIs) compared to current CFC metered dose inhalers. ERS Abstract

    Google Scholar 

  5. Köhler D, Fleischer W, Matthys H (1986) Inhalationstherapie, Verlag Gedon & Reuss, München

    Google Scholar 

  6. Mercer TT (1975) The deposition model of the task group on lung dynamics: A comparison with recent experimental data. Health physics 29:673–680

    Article  PubMed  CAS  Google Scholar 

  7. Schultz D, Ruble S, Ross D (1996) In vitro performance characteristics of two CFC-free metered dose inhalers (MDIs) with large and small volume spacers. ERS Abstract

    Google Scholar 

  8. Tansey I (1995) Die technologische Entwicklung des EPAQ®-Dosieraerosols (Salbutamolsulfat im FCKW-freien System). Br J of Clin Pract, Supp 79, S13–17

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cegla, U.H. (1998). Entwicklung alternativer FCKW-freier Dosieraerosole - Perspektiven. In: Schultz, K., Petro, W. (eds) Pneumologische Umweltmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72021-5_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72021-5_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72022-2

  • Online ISBN: 978-3-642-72021-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics